Literature DB >> 27841741

Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers.

Kathryn J Aikin1, Helen W Sullivan1, Amie C O'Donoghue1, Kevin R Betts1.   

Abstract

Information on the effects of promotional offers in direct-to-consumer prescription drug ads is limited. In two studies, we examined the effect of promotional offers (e.g., money-back guarantee) and ad type (creating prescription and over-the-counter drug ads by varying the presence of benefit and risk information). We found little effect of promotional offers. Adding benefit (risk) information to the ad increased consumers' knowledge of the benefit (risk) information and their efficacy (risk) perceptions. In most cases, adding risk information to an ad with benefit information increased risk knowledge and perceptions without decreasing benefit knowledge or perceptions.

Entities:  

Keywords:  Advertisements; DTC; OTC; coupons; drug safety; prescription drugs; promotional offers; risk comprehension; risk perception

Mesh:

Substances:

Year:  2016        PMID: 27841741      PMCID: PMC8218607          DOI: 10.1080/07359683.2016.1238262

Source DB:  PubMed          Journal:  Health Mark Q        ISSN: 0735-9683


  8 in total

1.  Consumers responses to coupons in direct-to-consumer advertising of prescription drugs.

Authors:  Nilesh S Bhutada; Christopher L Cook; Matthew Perri
Journal:  Health Mark Q       Date:  2009

2.  Randomized trial of risk information formats in direct-to-consumer prescription drug advertisements.

Authors:  Kathryn J Aikin; Amie C O'Donoghue; John L Swasy; Helen W Sullivan
Journal:  Med Decis Making       Date:  2011-06-20       Impact factor: 2.583

3.  Factors influencing consumers' attitudinal and behavioral responses to direct-to-consumer and over-the-counter drug advertising.

Authors:  Mina Lee; Karen Whitehill King; Leonard N Reid
Journal:  J Health Commun       Date:  2015-03-02

4.  Changes in direct-to-consumer pharmaceutical advertising following shifts from prescription-only to over-the-counter status.

Authors:  Jeremy A Greene; Niteesh K Choudhry; Aaron S Kesselheim; Troyen A Brennan; William Shrank
Journal:  JAMA       Date:  2012-09-12       Impact factor: 56.272

5.  Frequency of and reasons for medication non-fulfillment and non-persistence among American adults with chronic disease in 2008.

Authors:  Colleen A McHorney; Charles V Spain
Journal:  Health Expect       Date:  2010-09-23       Impact factor: 3.377

6.  Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.

Authors:  Richard L Kravitz; Ronald M Epstein; Mitchell D Feldman; Carol E Franz; Rahman Azari; Michael S Wilkes; Ladson Hinton; Peter Franks
Journal:  JAMA       Date:  2005-04-27       Impact factor: 56.272

7.  Presenting efficacy information in direct-to-consumer prescription drug advertisements.

Authors:  Amie C O'Donoghue; Helen W Sullivan; Kathryn J Aikin; Dhuly Chowdhury; Rebecca R Moultrie; Douglas J Rupert
Journal:  Patient Educ Couns       Date:  2013-12-25

8.  Direct-to-consumer television advertising exposure, diagnosis with high cholesterol, and statin use.

Authors:  Jeff Niederdeppe; Sahara Byrne; Rosemary J Avery; Jonathan Cantor
Journal:  J Gen Intern Med       Date:  2013-03-06       Impact factor: 5.128

  8 in total
  2 in total

1.  Assessing the Inclusion of Foil Items in a Scale to Measure Recognition of Health Messages.

Authors:  Helen W Sullivan; Wen-Hung Chen; Kevin R Betts
Journal:  Commun Methods Meas       Date:  2021-07-03

2.  The FDA's Diverse and Dynamic Activities in the Social and Behavioral Sciences: Advancing and Supporting Health Equity.

Authors:  Christine Lee; Melanie J McLean; Caroline J Huang; Anh Nguyen Zarndt; Kathryn J Aikin; Paula Rausch; Barbara R Cohen; Janine Delahanty; Danielle M Sholly; Wendy I Slavit; Ewa D Carlton
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.